← Insider buys
MCRB

Seres Therapeutics, Inc. · Healthcare

President and CEO Roger Pomerantz sold $114K of Seres Therapeutics, Inc.

Sold$113,950
$9.10Price
12,518Shares
−5%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Wed, Sep 5. Filed Thu, Sep 6, 5:08 PM ET, after the close. Not investment advice.